Thursday, July 3, 2025 7/3/2025

RNA oxidation in RAS-driven cancer

Award Number: R21CA293416
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/01/2024
PERIOD OF PERFORMANCE END DATE: 05/31/2026

Group Awards By:

View Award Description

RNA oxidation in RAS-driven cancer - ABSTRACT Chemical modifications in RNA play a crucial role in regulating gene expression in physiological and pathological conditions. One underexplored aspect of this regulation comes from reactive oxidative species (ROS), which modify nucleobases in RNA. Elevated levels of ROS and oxidative stress are prevalent in cancer cells, resulting from metabolic reprogramming and driven by factors such as activated RAS expression. However, our understanding of how ROS-induced RNA modifications affect gene expression in a cancer context remains limited. This study aims to fill this knowledge gap by exploring the roles and regulatory implications of oxidative modifications of RNA, with a focus on KRAS-driven redox perturbations in non-small cell lung cancer cells. The project has two main objectives. The first objective is to identify the patterns of oxidative modifications in RNA induced by oncogenic KRAS. This will be achieved through the combination of next-generation sequencing techniques and chemical methods to create high-resolution profiles of 8-oxoguanine modifications in RNA. The second objective is to understand the molecular players that ‘read’ these modifications. This will be done through biochemical and CLIP analysis techniques, focusing on proteins from the heterogeneous nuclear ribonucleoprotein (hnRNP) family. By elucidating these interactions, the study aims to uncover potential influences of oxidative RNA modifications on gene expression changes in cancer cells. The outcomes of this study will significantly contribute to our fundamental understanding of gene regulation in cancer. Since oxidative stress is a hallmark of many pathological states, the technological and conceptual advancements made in this study will also have broader relevance in understanding the role of oxidative RNA modifications in the pathogenesis of diseases.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $396,654 )
2024	2024	RU SCHOOL OF OSTEOPATHIC MEDICINE	42 E LAUREL RD	STRATFORD	NJ	08084	CAMDEN	USA	Cancer Biology Research	000	1	5/20/2024	NEW	$396,654
														Subtotal = $396,654

Grand Total All Awards = $396,654

Top

All Categories

About

Search

Reports

Data Submission

Award Information

RNA oxidation in RAS-driven cancer

Award Number: R21CA293416

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/01/2024

PERIOD OF PERFORMANCE END DATE: 05/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer